<--- Back to Details
First PageDocument Content
CD24 / CD43 / CD5 / Complement receptor 2
CD24
CD43
CD5
Complement receptor 2

Different approaches to harmonisation and standardisation - experience from ERIC, EMN, Euroflow and ESCCA Andy C. Rawstron on behalf of ERIC consortium

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 889,90 KB

Share Document on Facebook

Similar Documents

Historic Document and Summary Listing MSTRWD_CD43 1902 Notice: Auditors on Ditch Proceedings – Establishment May 21st 1989

Historic Document and Summary Listing MSTRWD_CD43 1902 Notice: Auditors on Ditch Proceedings – Establishment May 21st 1989

DocID: 1qgbg - View Document

Japan-Mexico WS  Abstract of Presentation Presentation Title: Is the CD43 molecule as a potential therapeutic target? Abstract:

Japan-Mexico WS Abstract of Presentation Presentation Title: Is the CD43 molecule as a potential therapeutic target? Abstract:

DocID: CZEg - View Document

Presentation: Yvonne Rosenstein

Presentation: Yvonne Rosenstein

DocID: Cws1 - View Document

Different approaches to harmonisation and standardisation - experience from ERIC, EMN, Euroflow and ESCCA Andy C. Rawstron on behalf of ERIC consortium

Different approaches to harmonisation and standardisation - experience from ERIC, EMN, Euroflow and ESCCA Andy C. Rawstron on behalf of ERIC consortium

DocID: qVgq - View Document

[removed]-707$[removed]The Journal of Immunology Copyright[removed]by The American Association of Immunologists Vol 151, [removed], No. 2, July 15, 1993 Printed in U S A .

[removed]-707$[removed]The Journal of Immunology Copyright[removed]by The American Association of Immunologists Vol 151, [removed], No. 2, July 15, 1993 Printed in U S A .

DocID: dxq3 - View Document